Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) [Phase 2]
Phase 2 study assessing the pharmacokinetics of NRL972 in patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ha…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages [NA]
This completed clinical trial evaluated simple fibrosis scoring methods and electronic reminder messages to identify nonalcoholic fatty live…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based Study
A completed biopsy-based study evaluates how common liver steatosis and nonalcoholic steatohepatitis are among patients undergoing bariatric…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Liver and Fat Regulation in Overweight Adolescent Girls [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating liver fat regulation and weight-related outcomes in overweight adolescent girls has completed, with re…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease [Phase 1, Phase 2]
Aspirin is being studied for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Phase 1/2. The trial is completed, and res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT） [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of Peg-interferon antiviral therapy for chronic hepatitis B in patients wit…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD） [Phase 2]
Phase 2 trial of HSK31679 in adults with hypercholesterolemia completed.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH [Phase 1, Phase 2]
A multiple ascending dose study of pegozafermin in participants with biopsy-confirmed NASH or NAFLD at high risk of NASH has completed phase…
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: Ketohexokinase Inhibition in NAFLD [Phase 2]
Phase 2 clinical trial examining ketohexokinase inhibition for nonalcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Amlexanox for Type 2 Diabetes and Obesity [Phase 2]
Phase 2 trial of amlexanox for type 2 diabetes mellitus and obesity was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease [Phase 3]
A Phase 3 trial evaluating efficacy and tolerability of lubiprostone in patients with nonalcoholic fatty liver disease (NAFLD) has been comp…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001) [Phase 2]
Phase 2 clinical trial of efinopegdutide (MK-6024) in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis has completed with r…
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Vitamin E for NASH Treatment in HIV Infected Individuals [Phase 2]
A Phase 2 trial studying vitamin E for treating nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in individuals with HIV wa…
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial assessing pharmacodynamics and safety of coadministered DGAT2 inhibitor and ACC inhibitor in participants with presum…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD [Phase 1, Phase 2]
Phase Ib/II trial evaluating GH509 versus placebo for NASH/NAFLD is ongoing; no results yet from the study.
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial investigating the effect of growth hormone on intrahepatic lipid content in patients with nonalcoholic fatty liver di…
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: Fatty Liver Disease in Obese Children [Phase 1, Phase 2]
Phase 1/2 clinical trial update on fatty liver disease in obese children has completed testing under Nemours Children's Clinic.
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis [Phase 2]
Phase 2 trial of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis (NASH) and liver cirrhosis has completed wit…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of Guanabenz for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis…
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis [Phase 2]
Phase 2 trial update of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis and stage 3 liver fibrosis; study com…
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial evaluating how fructose affects metabolism and MRI biomarkers in nonalcoholic fatty liver disease; study terminated with poste…
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects [Phase 2]
Phase 2 trial update for CRV431 in NASH patients with F2-F3 fibrosis; study completed and results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial update for FM101 in adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis.
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver [Phase 4]
Phase 4 clinical trial examining the impact of an oral anti-diabetic medication on liver fat in adults with type 2 diabetes and non-alcoholi…
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial assessing safety, tolerability, and efficacy of selonsertib, firsocostat, and cilofexor in adults with nonalcoholic steatohepa…